[HTML][HTML] Early prediction of success or failure of treatment with second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukemia
D Milojkovic, E Nicholson, JF Apperley… - …, 2009 - pmc.ncbi.nlm.nih.gov
Background Second-generation tyrosine kinase inhibitors induce cytogenetic responses in
approximately 50% of patients with chronic myeloid leukemia in chronic phase in whom …
approximately 50% of patients with chronic myeloid leukemia in chronic phase in whom …
Early prediction of success or failure of treatment with second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukemia
D Milojkovic, E Nicholson, JF Apperley… - …, 2010 - eprints.gla.ac.uk
Background Second-generation tyrosine kinase inhibitors induce cytogenetic responses in
approximately 50% of patients with chronic myeloid leukemia in chronic phase in whom …
approximately 50% of patients with chronic myeloid leukemia in chronic phase in whom …
Early prediction of success or failure of treatment with second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukemia.
D Milojkovic, E Nicholson, JF Apperley… - …, 2009 - europepmc.org
Background Second-generation tyrosine kinase inhibitors induce cytogenetic responses in
approximately 50% of patients with chronic myeloid leukemia in chronic phase in whom …
approximately 50% of patients with chronic myeloid leukemia in chronic phase in whom …
[PDF][PDF] Early prediction of success or failure of treatment with second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukemia
D Milojkovic, E Nicholson, JF Apperley, TL Holyoake… - …, 2010 - academia.edu
Background Second-generation tyrosine kinase inhibitors induce cytogenetic responses in
approximately 50% of patients with chronic myeloid leukemia in chronic phase in whom …
approximately 50% of patients with chronic myeloid leukemia in chronic phase in whom …
Early prediction of success or failure of treatment with second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukemia
D Milojkovic, E Nicholson, JF Apperley… - …, 2010 - pubmed.ncbi.nlm.nih.gov
Background Second-generation tyrosine kinase inhibitors induce cytogenetic responses in
approximately 50% of patients with chronic myeloid leukemia in chronic phase in whom …
approximately 50% of patients with chronic myeloid leukemia in chronic phase in whom …
Early prediction of success or failure of treatment with second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukemia
D Milojkovic, E Nicholson, JF Apperley… - …, 2010 - mdanderson.elsevierpure.com
Background: Second-generation tyrosine kinase inhibitors induce cytogenetic responses in
approximately 50% of patients with chronic myeloid leukemia in chronic phase in whom …
approximately 50% of patients with chronic myeloid leukemia in chronic phase in whom …
[PDF][PDF] Early prediction of success or failure of treatment with second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukemia
D Milojkovic, E Nicholson, JF Apperley, TL Holyoake… - haematologica, 2010 - Citeseer
Background Second-generation tyrosine kinase inhibitors induce cytogenetic responses in
approximately 50% of patients with chronic myeloid leukemia in chronic phase in whom …
approximately 50% of patients with chronic myeloid leukemia in chronic phase in whom …
[引用][C] Early prediction of success or failure of treatment with second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukemia
D MILOJKOVIC, E NICHOLSON… - Haematologica …, 2010 - pascal-francis.inist.fr
Early prediction of success or failure of treatment with second-generation tyrosine kinase
inhibitors in patients with chronic myeloid leukemia CNRS Inist Pascal-Francis CNRS …
inhibitors in patients with chronic myeloid leukemia CNRS Inist Pascal-Francis CNRS …
[HTML][HTML] Early prediction of success or failure of treatment with second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukemia
D Milojkovic, E Nicholson, JF Apperley… - …, 2010 - haematologica.org
Background Second-generation tyrosine kinase inhibitors induce cytogenetic responses in
approximately 50% of patients with chronic myeloid leukemia in chronic phase in whom …
approximately 50% of patients with chronic myeloid leukemia in chronic phase in whom …
[PDF][PDF] Early prediction of success or failure of treatment with second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukemia
D Milojkovic, E Nicholson, JF Apperley, TL Holyoake… - …, 2010 - academia.edu
Background Second-generation tyrosine kinase inhibitors induce cytogenetic responses in
approximately 50% of patients with chronic myeloid leukemia in chronic phase in whom …
approximately 50% of patients with chronic myeloid leukemia in chronic phase in whom …